Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 405

1.

Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases.

Bartzokis G, Tishler TA, Shin IS, Lu PH, Cummings JL.

Ann N Y Acad Sci. 2004 Mar;1012:224-36.

PMID:
15105269
[PubMed - indexed for MEDLINE]
2.

MRI evaluation of basal ganglia ferritin iron and neurotoxicity in Alzheimer's and Huntingon's disease.

Bartzokis G, Tishler TA.

Cell Mol Biol (Noisy-le-grand). 2000 Jun;46(4):821-33.

PMID:
10875443
[PubMed - indexed for MEDLINE]
3.

MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects.

Bartzokis G, Cummings JL, Markham CH, Marmarelis PZ, Treciokas LJ, Tishler TA, Marder SR, Mintz J.

Magn Reson Imaging. 1999 Feb;17(2):213-22.

PMID:
10215476
[PubMed - indexed for MEDLINE]
4.

In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging.

Bartzokis G, Sultzer D, Cummings J, Holt LE, Hance DB, Henderson VW, Mintz J.

Arch Gen Psychiatry. 2000 Jan;57(1):47-53.

PMID:
10632232
[PubMed - indexed for MEDLINE]
5.

Prevalent iron metabolism gene variants associated with increased brain ferritin iron in healthy older men.

Bartzokis G, Lu PH, Tishler TA, Peters DG, Kosenko A, Barrall KA, Finn JP, Villablanca P, Laub G, Altshuler LL, Geschwind DH, Mintz J, Neely E, Connor JR.

J Alzheimers Dis. 2010;20(1):333-41. doi: 10.3233/JAD-2010-1368.

PMID:
20164577
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

MR evaluation of age-related increase of brain iron in young adult and older normal males.

Bartzokis G, Beckson M, Hance DB, Marx P, Foster JA, Marder SR.

Magn Reson Imaging. 1997;15(1):29-35.

PMID:
9084022
[PubMed - indexed for MEDLINE]
7.

Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.

Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD.

Brain. 1991 Aug;114 ( Pt 4):1953-75.

PMID:
1832073
[PubMed - indexed for MEDLINE]
8.

In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI.

Bartzokis G, Sultzer D, Mintz J, Holt LE, Marx P, Phelan CK, Marder SR.

Biol Psychiatry. 1994 Apr 1;35(7):480-7.

PMID:
8018799
[PubMed - indexed for MEDLINE]
9.

In vivo MR evaluation of age-related increases in brain iron.

Bartzokis G, Mintz J, Sultzer D, Marx P, Herzberg JS, Phelan CK, Marder SR.

AJNR Am J Neuroradiol. 1994 Jun;15(6):1129-38.

PMID:
8073983
[PubMed - indexed for MEDLINE]
10.

A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains.

Connor JR, Snyder BS, Arosio P, Loeffler DA, LeWitt P.

J Neurochem. 1995 Aug;65(2):717-24.

PMID:
7616228
[PubMed - indexed for MEDLINE]
11.

Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.

Thompson K, Menzies S, Muckenthaler M, Torti FM, Wood T, Torti SV, Hentze MW, Beard J, Connor J.

J Neurosci Res. 2003 Jan 1;71(1):46-63.

PMID:
12478613
[PubMed - indexed for MEDLINE]
12.

Gender and iron genes may modify associations between brain iron and memory in healthy aging.

Bartzokis G, Lu PH, Tingus K, Peters DG, Amar CP, Tishler TA, Finn JP, Villablanca P, Altshuler LL, Mintz J, Neely E, Connor JR.

Neuropsychopharmacology. 2011 Jun;36(7):1375-84. doi: 10.1038/npp.2011.22. Epub 2011 Mar 9.

PMID:
21389980
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Brain iron and ferritin in Parkinson's and Alzheimer's diseases.

Jellinger K, Paulus W, Grundke-Iqbal I, Riederer P, Youdim MB.

J Neural Transm Park Dis Dement Sect. 1990;2(4):327-40.

PMID:
2078310
[PubMed - indexed for MEDLINE]
14.

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores.

Bartzokis G, Aravagiri M, Oldendorf WH, Mintz J, Marder SR.

Magn Reson Med. 1993 Apr;29(4):459-64.

PMID:
8464361
[PubMed - indexed for MEDLINE]
15.

Transferrin and iron in normal, Alzheimer's disease, and Parkinson's disease brain regions.

Loeffler DA, Connor JR, Juneau PL, Snyder BS, Kanaley L, DeMaggio AJ, Nguyen H, Brickman CM, LeWitt PA.

J Neurochem. 1995 Aug;65(2):710-24.

PMID:
7616227
[PubMed - indexed for MEDLINE]
16.

Cerebrospinal fluid ferritin levels of patients with Parkinson's disease, Alzheimer's disease, and multiple system atrophy.

Kuiper MA, Mulder C, van Kamp GJ, Scheltens P, Wolters EC.

J Neural Transm Park Dis Dement Sect. 1994;7(2):109-14.

PMID:
7710663
[PubMed - indexed for MEDLINE]
17.

Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: an in vivo MR study.

Zhang J, Zhang Y, Wang J, Cai P, Luo C, Qian Z, Dai Y, Feng H.

Brain Res. 2010 May 12;1330:124-30. doi: 10.1016/j.brainres.2010.03.036. Epub 2010 Mar 18.

PMID:
20303339
[PubMed - indexed for MEDLINE]
18.
19.

Brain ferritin iron may influence age- and gender-related risks of neurodegeneration.

Bartzokis G, Tishler TA, Lu PH, Villablanca P, Altshuler LL, Carter M, Huang D, Edwards N, Mintz J.

Neurobiol Aging. 2007 Mar;28(3):414-23. Epub 2006 Mar 24.

PMID:
16563566
[PubMed - indexed for MEDLINE]
20.

Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases.

Mattson MP, Pedersen WA, Duan W, Culmsee C, Camandola S.

Ann N Y Acad Sci. 1999;893:154-75. Review.

PMID:
10672236
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk